All News
Filter News
Found 808,690 articles
-
Cardea Bio and Nanosens Innovations look to combine companies
9/6/2019
The Board of Directors of Cardea Bio and the Board of Directors of Nanosens Innovations have each authorized the respective companies to proceed with a proposed business combination.
-
Navidea Biopharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference
9/6/2019
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that its Chief Executive Officer, Jed Latkin, will present a corporate overview of the Company at the H.C. Wainwright 21st Annual Global Investment Conference
-
Boston Sarcoidosis Education Conference to Take Place September 14, 2019
9/6/2019
The Foundation for Sarcoidosis Research (FSR) is teaming up with internationally-recognized physicians to host an educational conference for people affected by sarcoidosis in Boston.
-
Ridgeback Biotherapeutics LP announces receipt of Breakthrough Therapy designation from FDA for mAb114
9/6/2019
Ridgeback Biotherapeutics LP, a closely held biotechnology company, today announced that the Food and Drug Administration has recently granted mAb114, an experimental treatment for Ebola, Breakthrough Therapy designation.
-
DromosPTM™, an Innovative Software for Specialty Pharmacies
9/6/2019
Henry Ford Innovations (HFI) has signed an exclusive licensing agreement with a Detroit software and health care company to market an innovative software application that will be appealing to specialty pharmacies worldwide.
-
FDA approves first treatment for patients with rare type of lung disease
9/6/2019
The U.S. Food and Drug Administration today approved Ofev (nintedanib) capsules to slow the rate of decline in pulmonary function in adults with interstitial lung disease associated with systemic sclerosis or scleroderma, called SSc-ILD
-
National Study Seeks Earlier Diagnosis of ATTR Cardiac Amyloidosis in Minorities
9/6/2019
Researchers at Boston Medical Center (BMC) and Boston University School of Medicine (BUSM), in collaboration with Columbia University Irving Medical Center (CUIMC), are leading a national, multi-site study aimed to achieve earlier diagnosis of transthyretin cardiac amyloidosis (ATTR-CM).
-
Nephron, UofSC researchers improving medication safety through automation
9/6/2019
Nephron Pharmaceuticals Corporation has joined forces with the University of South Carolina's College of Engineering and Computing and the College of Pharmacy to design and implement an automation process that significantly boosts production of pre-filled medication, reducing the physical burden on workers and increasing patient safety.
-
MEDIA ADVISORY—Future Pharma: ALULA Senior Principal Danielle Geissler and ALULA Partner Kim Huggins To Present “Achieving Digital Transformation: Critical Drivers for the ‘New Way of Working’”
9/6/2019
Danielle Geissler, Ph.D., senior principal, ALULA – Dr. Geissler is a multi-industry expert at applying the science of behavior to individual and organizational transformation.
-
Koneksa Health Announces Poster Presentation at ASCO Quality Care Symposium
9/6/2019
Koneksa Health today announced a poster presentation of a study expanding initial findings that real-world data from activity trackers can predict hospitalization risk for patients having chemoradiotherapy better than traditional clinical assessments like performance status.
-
Mallinckrodt Announces Settlement in Principle to Resolve "Track 1" Opioid Cases with the Ohio Counties of Cuyahoga and Summit
9/6/2019
Mallinckrodt plc (NYSE: MNK), along with its wholly owned subsidiaries Mallinckrodt LLC and SpecGx LLC, today announced that it has reached a settlement in principle with Cuyahoga and Summit Counties in Ohio in connection with lawsuits pending in multidistrict opioid litigation (MDL) in the U.S. District Court for the Northern District of Ohio
-
The Bitar Cosmetic Surgery Institute Receives "Top Plastic Surgeon - EAST" in the Aesthetic Everything® 2019 Aesthetic and Cosmetic Medicine Awards
9/6/2019
George Bitar, MD, FACS along with The Bitar Cosmetic Surgery Institute received Top Aesthetic Doctors and Top Plastic Surgeon – EAST in the Aesthetic Everything® 2019 Awards.
-
Kaiser Permanente earns EPA green energy award
9/6/2019
Kaiser Permanente, the nation's largest nonprofit, integrated health care system, has received a U.S. Environmental Protection Agency 2019 Green Power Leadership Award in recognition of its use of renewable sources of energy to power its 39 hospitals and more than 700 medical offices.
-
Face The Future Foundation Presents Check For $300,000 To UI Health Craniofacial Center
9/6/2019
Today, Face the Future Foundation's (FFF) Board of Directors will join UI Health Craniofacial Center's medical staff, allied health professionals and others for the center's 70th anniversary celebration.
-
Epredia Attending 31st European Congress of Pathology, Its First Global Pathology Conference Since Company Launch
9/6/2019
Epredia, a global leader in precision cancer diagnostics, has today announced that it will be attending the 31st European Congress of Pathology (ECP) later this week.
-
TransPerfect “Victory Lap” Run/Walk Raises More Than $140,000 for the V Foundation for Cancer Research
9/6/2019
TransPerfect, the world’s largest provider of language and technology solutions for global business, today announced that it has surpassed $140,000 in funds raised for the V Foundation for Cancer Research thus far in 2019.
-
BC PharmaCare Expands Biosimilar Switching Program
9/6/2019
Biosimilars Canada, a national association representing Canada's biosimilar medicines industry, today congratulated the Government of British Columbia for building on the success of its biosimilar switching program and called on other provinces to implement similar programs.
-
Endo Announces Submission of Biologics License Application to FDA for Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite
9/6/2019
Endo International plc (NASDAQ: ENDP) announced today that the Company has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for collagenase clostridium histolyticum (CCH) for the treatment of cellulite in the buttocks.
-
Microbubbles and Ultrasound Can Help Treat Heart Attacks
9/6/2019
Doctors are using microbubbles and ultrasound to treat heart attacks -- deploying these traditional diagnostic tools in an attempt to reopen tiny blood vessels, reduce scar size and restore heart function, according to a study described Friday at a medical conference in Chicago.
-
Dr. Reddy's Laboratories Limited to Present at the Morgan Stanley Annual Global Healthcare Conference
9/6/2019
Dr. Reddy’s Laboratories Ltd (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) announced that the Company will be presenting at the Morgan Stanley 17th Annual Global Healthcare Conference on Tuesday, September 10th, 2019, in New York City.